The third section is being put together by Drs. Walters 
and Rich and will include possible anticipated concerns and 
adverse effects on the one hand, and on the other, some examples 
of the acceptability of human somatic-cell gene therapy. 
A final section will list some references, a few articles 
and books for those who wish to study the subject further. This 
section will include an offer to send some NIH materials such as 
copies of the "Points to Consider", the Guidelines and the OPRR 
pamphlet, upon request. 
Our working 
to the Human Gene 
April 24th. When 
will v presented to 
be 
Chairman, Working 
group plans to present a draft of the document 
Therapy Subcommittee when it meets next on 
the Subcommittee has finalized the document, i 
the RAC for approval. 
Anne R. Witherby 
Public Representative and 
Group on a General Information Document. 
Additions, February 11, 1987 
1 ♦ The third section will include two parts: 
(1) the above, as stated, which refers to a portion 
of the Introduction in the "Points to Consider" [ page 6 (8) and 
page 7 (9) , ( 10) ] . 
(2) a basic summary of numbers I through IV in the 
"Points to Consider". 
2 . Please include Dr. Susan K. Gottesman as a consultant to 
the Working Group on a General Information Document. 
SrtvJ 
[ 162 ] 
Recombinant DNA Research, Volume 1 1 
